Back to results
US 2025/0222007 A1Published application
Preparation of low molecular weight polylactic acid and the use thereof
AssigneeAL Andalous for Pharmaceutical Industries
InventorsAhmed Fathy Hanafy, Mohamed Ahmed Ibrahim
Life of this patent
Estimating the term…
Abstract
Provided herein are methods and compositions related to a pharmaceutical composition for eye injection to certain ocular cavities and/or eye surfaces, or upon injection in ocular tissues. The pharmaceutical composition comprises an active pharmaceutical ingredient and a low molecular weight crystalline biodegradable polymer and a biocompatible solvent.
Claims23
A pharmaceutical composition comprising an active pharmaceutical ingredient, a low molecular weight crystalline biodegradable polymer, and a biocompatible solvent.
19-25. (canceled)
27-31. (canceled)
33-36. (canceled)
Dependencies are inferred from the claim text.